Curanex Partners with Strategic Investor Relations to Boost Visibility
Partnership Announcement: Curanex Pharmaceuticals has partnered with Strategic Investor Relations to improve its visibility in the financial community.
Investor Engagement: The collaboration aims to enhance communication strategies and educate current and potential investors about Curanex's innovative pipeline and strategic initiatives.
Focus on Botanical Drugs: Curanex will highlight its approach to developing high-efficacy botanical drugs with de-risked clinical pathways.
Market Positioning: The partnership will also emphasize Curanex's positioning within the rapidly expanding botanical drug market.
Get Free Real-Time Notifications for Any Stock
Analyst Views on CURX
About CURX
About the author
"20 Stocks Making Moves in Premarket as Bullish Shares Rise by 12%"
Bullish Earnings Report: Bullish (BLSH) shares surged 12.3% in pre-market trading after reporting a profit of 93 cents per share for Q2, a significant improvement from a loss of $1.03 per share a year ago, with revenues rising to $58.63 million.
Notable Gainers: 89bio, Inc. (ETNB) saw an 82.9% increase due to an acquisition by Roche, while other stocks like Psyence Biomedical Ltd (PBM) and Aptevo Therapeutics Inc (APVO) also experienced significant gains in pre-market trading.
Major Losers: Wheeler Real Estate Investment Trust, Inc. (WHLR) dropped 23.1% following a reverse stock split announcement, and other companies like Office Properties Income Trust (OPI) and Educational Development Corporation (EDUC) also faced declines in pre-market trading.
Market Overview: The pre-market trading session showed a mix of sharp gains and losses among various stocks, reflecting a volatile market environment influenced by earnings reports and corporate announcements.
